Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

42.97
BATS BZX Real-Time Price
As of 3:57pm ET
 -0.45 / -1.04%
Today’s Change
36.71
Today|||52-Week Range
45.58
+8.02%
Year-to-Date
The Internet of Medical Things: 6 Stocks in Focus
10:08am / Zacks.com - Paid Partner Content
GlaxoSmithKline Appoints Insider Walmsley as new CEO
Sep 20 / TheStreet.com - Paid Partner Content
Glaxo/J&J File BLA for Rheumatoid Arthritis Drug in the U.S.
9:29am / Zacks.com - Paid Partner Content
5 Things You Must Know Before the Market Opens Tuesday
Sep 20 / TheStreet.com - Paid Partner Content
Apple iPhone Calling Big Pharma: We Can Help You Develop Better Drugs
Sep 25 / MotleyFool.com - Paid Partner Content
Sanofi in a State of Suspended Animation Until Boehringer Ingelheim Swap
Sep 19 / GuruFocus News - Paid Partner Content
3 Bold Bets on the Future of Biotechnology
Sep 25 / MotleyFool.com - Paid Partner Content
Epizyme Receives Milestone from Glaxo for Lymphoma Drug
Sep 16 / Zacks.com - Paid Partner Content
The skill employers really want from new recruits
Sep 23 / CNNMoney.com
FDA Panel Suggests Removing Warning from Pfizer's Chantix
Sep 15 / Zacks.com - Paid Partner Content
The Pros and Cons of Buying Gilead Sciences Stock
Sep 22 / MotleyFool.com - Paid Partner Content
Glaxo (GSK) Publishes Phase III Data on Shingles Vaccine
Sep 15 / Zacks.com - Paid Partner Content
Frontrunning: September 21
Sep 21 / Investing Channel - Paid Partner Content
FDA AdCom Votes on Pfizer and Spectrum Drugs - What Next?
Sep 15 / Zacks.com - Paid Partner Content
European Markets Mixed Ahead of Fed, BOJ Rate Calls on Wednesday
Sep 20 / TheStreet.com - Paid Partner Content
You'll Never Guess Which Pharma Could Knock Gilead Sciences Off Its HIV Throne
Sep 14 / MotleyFool.com - Paid Partner Content
Meet Big Pharma's new female CEO
Sep 20 / CNNMoney.com
Glaxo/J&J File for Rheumatoid Arthritis Drug Sirukumab in EU
Sep 13 / Zacks.com - Paid Partner Content
GlaxoSmithKline (GSK) Stock Lower, Names Walmsley CEO
Sep 20 / TheStreet.com - Paid Partner Content
The Only Thing More Extraordinary Than GlaxoSmithKline's Growth Strategy Is That It's...
Sep 12 / MotleyFool.com - Paid Partner Content